The Leadership Team at InflaRx guides the strategic vision and operational execution of the company, focusing on advancing its innovative anti-C5a therapies. Comprising seasoned executives with expertise in scientific research, financial management, and corporate development, the team collaborates to drive clinical advancements, secure funding, and navigate regulatory pathways, ensuring the successful progression of its biopharmaceutical pipeline.